Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Global X Lithium & Battery Tech ETF (LIT) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance

Global X Lithium & Battery Tech ETFTrade
Relay Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Global X Lithium & Battery Tech ETF vs Relay Therapeutics Inc. Common Stock — how do they compare? Global X Lithium & Battery Tech ETF trades at $69.72 (market cap $1.45B), while Relay Therapeutics Inc. Common Stock trades at $17.89 (market cap $3.82B). The key difference: Relay Therapeutics Inc. Common Stock is far larger — about 2.6× Global X Lithium & Battery Tech ETF's market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, Global X Lithium & Battery Tech ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Global X Lithium & Battery Tech ETF for 56 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.

LITRLAY
Market Cap
$1.45B$3.82B
Volume
89,3924,332,079
Sector
Commodities - Metals/AgricultureHealth
52-Week High
$91.62$20.75
52-Week Low
$53.92$6.03
Typical Hold Time
56 Days0 Days
Enterprise Value
—$2.93B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Global X Lithium & Battery Tech ETF

LIT (Global X Lithium & Battery Tech ETF) trades at $69.51, down 2.2% with mixed technical signals showing a bullish overall trend but bearish moving averages and oscillators. Recent news highlights significant short interest decline (53.1% drop in September 2026) and positive catalysts from EV adoption trends. The ETF's performance reflects ongoing volatility in lithium markets amid shifting commodity prices and global electrification policies.

Outlook remains driven by long-term EV growth, though near-term risks include lithium price volatility and geopolitical tensions. Investment opportunity lies in exposure to battery technology leaders, balanced by sector-specific supply chain and regulatory uncertainties that could impact shareholder returns.

Relay Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LIT

No sentiment data available yet.

RLAY
100% Buy0% Sell
Avg holding period · 0 Days

About Global X Lithium & Battery Tech ETF

LIT invests in the full lithium cycle, from mining and refining to battery production and EV manufacturing. It tracks the Solactive Global Lithium Index, with top holdings including Rio Tinto, Albemarle, and Tesla, as well as major battery makers like Samsung SDI.

Read more on LIT →

About Relay Therapeutics Inc. Common Stock

Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.

Read more on RLAY →